XETRA - Delayed Quote EUR
Novavax, Inc. (NVV1.DE)
7.85
-0.04
(-0.53%)
At close: February 17 at 5:35:45 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALTON GREGG H Director | Stock Award(Grant) | Dec 31, 2024 | 18,385 |
| CASEY MARK J Officer | Conversion of Exercise of derivative security | Feb 28, 2025 | 31,973 |
| JACOBS JOHN C Chief Executive Officer | Conversion of Exercise of derivative security | Feb 28, 2025 | 136,732 |
| KELLY JAMES PATRICK Chief Financial Officer | Conversion of Exercise of derivative security | Mar 7, 2025 | 69,251 |
| KING RACHEL K Director | Sale | Dec 13, 2024 | 14,770 |
| MCGLYNN MARGARET G Director | Stock Award(Grant) | Dec 31, 2024 | 15,168 |
| O'HARA ELAINE Officer | Conversion of Exercise of derivative security | Feb 28, 2025 | 57,481 |
| RODGERS RICHARD J. Director | Conversion of Exercise of derivative security | Oct 29, 2024 | 14,270 |
| TRIZZINO JOHN J President | Conversion of Exercise of derivative security | Mar 7, 2025 | 68,061 |
| YOUNG JAMES FRANCIS Director | Sale | Dec 31, 2024 | 51,760 |
Related Tickers
88Q.DE 4basebio PLC
13.00
0.00%
7V0.DE Darwin AG
28.20
0.00%
BIO.DE Biotest Aktiengesellschaft
42.60
-0.47%
BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
9VC.DE Atai Life Sciences N.V.
1.2630
+0.44%
VX1.DE Vertex Pharmaceuticals Incorporated
372.85
-4.85%
AYJ.DE Valneva SE
2.9200
+0.14%
NP5.DE Newron Pharmaceuticals S.p.A.
8.84
+2.08%
HPHA.DE Heidelberg Pharma AG
3.1200
-1.58%
BBZA.DE BB Biotech AG
30.15
-1.95%